Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue, Robert A. Weinberg
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 10, pp. 611-629
Open Access | Times Cited: 2193

Showing 1-25 of 2193 citing articles:

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi, Ilio Vitale, Stuart A. Aaronson, et al.
Cell Death and Differentiation (2018) Vol. 25, Iss. 3, pp. 486-541
Open Access | Times Cited: 5331
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Anushka Dongre, Robert A. Weinberg
Nature Reviews Molecular Cell Biology (2018) Vol. 20, Iss. 2, pp. 69-84
Closed Access | Times Cited: 3066
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta, Artem Sokolov, Andrew J. Gentles, et al.
Cell (2018) Vol. 173, Iss. 2, pp. 338-354.e15
Open Access | Times Cited: 1754
EMT in cancer
Thomas Brabletz, Raghu Kalluri, M. Ángela Nieto, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 2, pp. 128-134
Closed Access | Times Cited: 1652
NRF2 and the Hallmarks of Cancer
Montserrat Rojo de la Vega, Eli Chapman, Donna D. Zhang
Cancer Cell (2018) Vol. 34, Iss. 1, pp. 21-43
Open Access | Times Cited: 1327
Epithelial Mesenchymal Transition in Tumor Metastasis
Vivek Mittal
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 13, Iss. 1, pp. 395-412
Open Access | Times Cited: 1263
Drug resistance and combating drug resistance in cancer
Xuan Wang, Haiyun Zhang, Xiaozhuo Chen
Cancer Drug Resistance (2019)
Open Access | Times Cited: 873
Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
Andrew L. Ji, Adam J. Rubin, Kim Thrane, et al.
Cell (2020) Vol. 182, Iss. 2, pp. 497-514.e22
Open Access | Times Cited: 786
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 764
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 750
Targeting metastatic cancer
Karuna Ganesh, Joan Massagué
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 34-44
Open Access | Times Cited: 748
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
Doménico Ribatti, Roberto Tamma, Tiziana Annese
Translational Oncology (2020) Vol. 13, Iss. 6, pp. 100773-100773
Open Access | Times Cited: 734
Unmasking senescence: context-dependent effects of SASP in cancer
Douglas V. Faget, Qihao Ren, Sheila A. Stewart
Nature reviews. Cancer (2019) Vol. 19, Iss. 8, pp. 439-453
Closed Access | Times Cited: 654
TGFβ biology in cancer progression and immunotherapy
Rik Derynck, Shannon J. Turley, Rosemary J. Akhurst
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 1, pp. 9-34
Open Access | Times Cited: 649
The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi, Frédéric J. de Sauvage
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 1, pp. 39-56
Closed Access | Times Cited: 602
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
Yun Zhang, Robert A. Weinberg
Frontiers of Medicine (2018) Vol. 12, Iss. 4, pp. 361-373
Open Access | Times Cited: 600
Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance
Jiao Li, Dan Sun, Wenchen Pu, et al.
Trends in cancer (2020) Vol. 6, Iss. 4, pp. 319-336
Closed Access | Times Cited: 549
Extracellular matrix and its therapeutic potential for cancer treatment
Jiacheng Huang, Lele Zhang, Dalong Wan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 536
Dynamic EMT: a multi‐tool for tumor progression
Simone Brabletz, Harald Schuhwerk, Thomas Brabletz, et al.
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 504
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Marta Prieto‐Vila, Ryou Takahashi, Wataru Usuba, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 12, pp. 2574-2574
Open Access | Times Cited: 446
Involvement of partial EMT in cancer progression
Masao Saitoh
The Journal of Biochemistry (2018) Vol. 164, Iss. 4, pp. 257-264
Open Access | Times Cited: 443
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang, Li Zhou, Na Xie, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 430
Linking EMT programmes to normal and neoplastic epithelial stem cells
Arthur W. Lambert, Robert A. Weinberg
Nature reviews. Cancer (2021) Vol. 21, Iss. 5, pp. 325-338
Closed Access | Times Cited: 403
Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Jae Hyung Park, Woo Yang Pyun, Hyun Woo Park
Cells (2020) Vol. 9, Iss. 10, pp. 2308-2308
Open Access | Times Cited: 399
Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma
Toshiro Hara, Rony Chanoch-Myers, Nathan D. Mathewson, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 779-792.e11
Open Access | Times Cited: 394
Page 1 - Next Page

Scroll to top